Custom DNA synthesis, coupled with bioinformatics tools and high-throughput capabilities, has made it possible to genetically engineer healthier, cleaner, more sustainable solutions for the world’s most pressing challenges. Join us to watch an overview of how synthetic biology innovations are applying engineering principles to biological research. What you’ll learn:
Commercial Product Manager – Synthetic Biology, Integrated DNA Technologies
Tom Speedy is the Director of Business Development of Synthetic Biology at IDT where he provides guidance for the strategy and development of the Synthetic Biology business, in addition to technical support to the sales team and to customers. Prior to joining IDT, Tom worked at Gen9, Oxford Genetics, Innova, and AbD Serotec/Morphosys. He is an active member of the synthetic biology community and currently serves as an Advisory Board Member for BioPartner UK.